Milestone Scientific Inc. (MLSS) - EV/EBITDA Multiple
Milestone Scientific (MLSS) generates revenue through the sale of advanced Wand systems designed for comfortable dental injections. A steady cash flow is driven by consistent demand for replacement parts. The company's valuation evolution reflects an EV/EBITDA ratio of 0.00. However, growth is hindered by practitioners' adherence to legacy methods, the high cost of equipment relative to simple alternatives, and challenges in securing insurance reimbursements.
Analytical breakdowns for milestonescientific.com (MLSS)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Milestone Scientific|MLSS - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Milestone Scientific Inc.|MLSS - Aggregate Debt Obligations|Debt to Book Value Milestone Scientific Corporation|MLSS - Company Long-Term Debts|Company Short-Term Debt Milestone Scientific|Quick Ratio milestonescientific.com
- business earnings and investment ratios data:
MLSS - Company Net Income|Expected Profit Milestone Scientific|MLSS - Price to Earnings Multiple|Projected Price to Earnings Milestone Scientific|MLSS - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Milestone Scientific Corporation|MLSS - Operating income before deduction of amortization|Earnings per share for the last twelve months Milestone Scientific|MLSS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth milestonescientific.com|MLSS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Milestone Scientific
Summary company analysis:Milestone Scientific Corp (MLSS)
The history of EV/EBITDA values for Milestone Scientific (MLSS) reflects the efficiency with which the implementation of ESG precision dosing technologies has been integrated into the business capitalization. This multiple compares the total enterprise value with its operating profit before depreciation and taxes, allowing investors to determine the real value of assets regardless of debt load and financing structure to assess investment attractiveness.
Competitors of Milestone Scientific
Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|Utah Medical (UTMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio KORU Medical|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|microbotmedical.com (MBOT) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pro-Dex (PDEX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZTEK (Zentek Ltd)|EV/EBITDA Multiple ELUT (Elutia Corp)|NEXGEL Inc (NXGL) - Company Value to EBITDA|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Harvard Bioscience Inc. HBIO|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|MHUA: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|Company Value to EBITDA Callan JMB Corp CJMB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atrion Corporation (ATRI)|neurometrix.com - Enterprise Value to Operating Income Before Depreciation
